Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial

作者：Knut Jørgen Labori, Svein Olav Bratlie, Bodil T. Andersson, Jon‐Helge Angelsen, Christina Biörserud, Bergþór Björnsson, Erling Audun Bringeland, Nils Oskar Elander, Herish Garresori, Jon Erik Grønbech, Johan Haux, Oskar Hemmingsson, Maria Gustafsson Liljefors, Tor Åge Myklebust, Linn Såve Nymo, Katriina Johanna Peltola, Per Pfeiffer, Ville J. Sallinen, Per Gunnar Sandstrøm, Ernesto Sparrelid, Helge Stenvold, Kjetil Søreide, Bobby Tingstedt, Caroline Sophie Verbeke, Daniel Öhlund, Leif Klint, Svein Dueland, Kristoffer Lassen, Eirik Kjus Aahlin, Charlotte Bratthäll, Asif Halimi, Ingunn Hatlevoll, Margareta Heby, Arto Kokkola, Maximilian Kordes, Stina Lindblad, Linda Lundgren, Michael Bau Mortensen, Kim Erlend Mortensen, Jan Persson, Elena B. Rangelova, Elin Rønne, Oddvar Mathias Sandvik, Jon Arne Søreide, Caroline Vilhav, Kim Waardal, Johanna Hansson Wennerblom, Caroline Williamsson, Sheraz Yaqub · 发表于：˜The œLancet. Gastroenterology & hepatology · 年份：2024 · DOI：10.1016/s2468-1253(23)00405-3 · 被引用次数：226 · 研究领域：Pancreatic and Hepatic Oncology Research、Head and Neck Cancer Studies、Cholangiocarcinoma and Gallbladder Cancer Studies